1. Home
  2. ENOV vs TFIN Comparison

ENOV vs TFIN Comparison

Compare ENOV & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • TFIN
  • Stock Information
  • Founded
  • ENOV 1995
  • TFIN 1981
  • Country
  • ENOV United States
  • TFIN United States
  • Employees
  • ENOV N/A
  • TFIN N/A
  • Industry
  • ENOV Fluid Controls
  • TFIN Major Banks
  • Sector
  • ENOV Industrials
  • TFIN Finance
  • Exchange
  • ENOV Nasdaq
  • TFIN Nasdaq
  • Market Cap
  • ENOV 1.6B
  • TFIN 1.5B
  • IPO Year
  • ENOV 2008
  • TFIN N/A
  • Fundamental
  • Price
  • ENOV $33.19
  • TFIN $59.29
  • Analyst Decision
  • ENOV Strong Buy
  • TFIN Hold
  • Analyst Count
  • ENOV 6
  • TFIN 4
  • Target Price
  • ENOV $51.00
  • TFIN $70.75
  • AVG Volume (30 Days)
  • ENOV 970.3K
  • TFIN 199.6K
  • Earning Date
  • ENOV 11-05-2025
  • TFIN 10-15-2025
  • Dividend Yield
  • ENOV N/A
  • TFIN N/A
  • EPS Growth
  • ENOV N/A
  • TFIN N/A
  • EPS
  • ENOV N/A
  • TFIN 0.44
  • Revenue
  • ENOV $2,189,576,000.00
  • TFIN $409,227,000.00
  • Revenue This Year
  • ENOV $9.13
  • TFIN $12.07
  • Revenue Next Year
  • ENOV $6.39
  • TFIN $14.74
  • P/E Ratio
  • ENOV N/A
  • TFIN $133.43
  • Revenue Growth
  • ENOV 14.40
  • TFIN 2.49
  • 52 Week Low
  • ENOV $25.47
  • TFIN $42.90
  • 52 Week High
  • ENOV $49.83
  • TFIN $110.58
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 61.78
  • TFIN 49.81
  • Support Level
  • ENOV $30.44
  • TFIN $56.86
  • Resistance Level
  • ENOV $33.85
  • TFIN $60.27
  • Average True Range (ATR)
  • ENOV 1.06
  • TFIN 2.51
  • MACD
  • ENOV 0.15
  • TFIN -0.45
  • Stochastic Oscillator
  • ENOV 82.86
  • TFIN 36.61

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks: